These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 26954325)
1. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere. Baker BK PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325 [TBL] [Abstract][Full Text] [Related]
2. New Pacific trade deal--good for pharma, bad for public health? Gornall J BMJ; 2015 Jul; 351():h3649. PubMed ID: 26155990 [No Abstract] [Full Text] [Related]
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
4. TPPA should not be adopted without a full, independent health assessment. Keating G; Freeman J; Macmillan A; Neuwelt P; Monasterio E N Z Med J; 2016 Feb; 129(1430):7-13. PubMed ID: 26914417 [No Abstract] [Full Text] [Related]
5. Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad. Luo J; Kesselheim AS AMA J Ethics; 2016 Jul; 18(7):727-35. PubMed ID: 27437823 [TBL] [Abstract][Full Text] [Related]
6. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts. Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767 [TBL] [Abstract][Full Text] [Related]
7. The high price of "free" trade: U.S. trade agreements and access to medicines. Lopert R; Gleeson D J Law Med Ethics; 2013; 41(1):199-223. PubMed ID: 23581666 [TBL] [Abstract][Full Text] [Related]
8. The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines. Luo J; Kesselheim AS JAMA; 2015 Oct; 314(15):1563-4. PubMed ID: 26291894 [No Abstract] [Full Text] [Related]
9. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment. Adekola TA Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136 [TBL] [Abstract][Full Text] [Related]
10. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]
12. How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand. Gleeson D; Lopert R; Reid P Health Policy; 2013 Oct; 112(3):227-33. PubMed ID: 23992756 [TBL] [Abstract][Full Text] [Related]
13. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia. Lexchin J; Gleeson D Int J Health Serv; 2016 Oct; 46(4):597-613. PubMed ID: 27516183 [TBL] [Abstract][Full Text] [Related]
14. TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION. Effingham AM Seton Hall Law Rev; 2016; 46(3):883-909. PubMed ID: 27066613 [No Abstract] [Full Text] [Related]
15. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa. Buckely M Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760 [No Abstract] [Full Text] [Related]
16. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines. Townsend B; Gleeson D; Lopert R Asia Pac J Public Health; 2016 Nov; 28(8):682-693. PubMed ID: 27920239 [TBL] [Abstract][Full Text] [Related]
17. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
18. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil. Rosenberg ST Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542 [TBL] [Abstract][Full Text] [Related]
19. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines]. Chaves GC; Oliveira MA; Hasenclever L; de Melo LM Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075 [TBL] [Abstract][Full Text] [Related]
20. Impact on access to medicines from TRIPS-Plus: a case study of Thai-US FTA. Kessomboon N; Limpananont J; Kulsomboon V; Maleewong U; Eksaengsri A; Paothong P Southeast Asian J Trop Med Public Health; 2010 May; 41(3):667-77. PubMed ID: 20578557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]